10.1186/s12933-021-01317-3 Summary Keywords c-GAS-STING pathway activation, defective lipid metabolism, diabetic kidney disease, inflammation, mitochondrial damage and dysfunction, podocyte-ANGPTL4, tubule-ANGPTL4 Citation Srivastava SP, Arora AV, Hamed M, Urval A, Dupati A, Xia S, Yoshida S and Inoki K (2026) Kidney angiopoietin-like protein 4 regulates fibrotic responses in diabetic kidney disease
If you are experiencing nosebleeds, it is likely due to other factors like dry air, dehydration, or other medications you may be taking
Our selection criteria focused on three things: mechanism of action (how the peptide actually works), quality of existing evidence (human trials where available, animal data where not), and real-world feedback from experienced users
Highlights: GLP-1 receptor agonists were associated with a slightly higher relative risk of nonarteritic anterior ischemic optic neuropathy (NAION) , although the one-year absolute risk remained only 0.04% A nationwide Swedish cohort study followed more than 293,000 adults with type 2 diabetes who started GLP-1 receptor agonists or SGLT-2 inhibitors